Please find attached copy of certificates under Regulation 74(5) of SEBI (Depository And Participants) Regulations, 2018 received from Kfin Technologies Limited for the quarter ended 31/March/2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sudarshan Pharma Industries submitted certificates from KFIN Technologies Limited, their Registrar & Share Transfer Agent, confirming compliance with SEBI regulations for the quarter ending 31 March 2026. The certificates from both NSDL and CDSL verify that details of securities dematerialized/rematerialized during the period were properly furnished to BSE Limited as required under Regulation 74(5). This is a standard quarterly compliance filing to maintain the company's listed status on BSE (Scrip Code: 543828).
This is a routine regulatory compliance filing with no direct impact on stock price or shareholder value. It simply confirms the company is following SEBI's mandatory procedures for tracking share dematerialization activities.